3rd Annual Oncology Biomarkers Congress

Over 150 delegates working in Oncology Biomarkers, Companion Diagnostics & Personalised Medicine

Over 25 presentations, case studies and panel discussions delivered by leading biotech companies, global pharma organisations & internationally renowned academic institutions.

Including 2 interactive streams:

  • Oncology Biomarkers: Strategies for Successful Discovery, Through to Clinical Translation
  • Companion Diagnostics, Patient Selection & Personalised Medicine

Co-located with the 2nd Annual Oncology Clinical Development Congress 2013

14 prescheduled one to one meetings, exhibition spaces and informal networking opportunities

Oxford Global is proud to present the 3rd Annual Oncology Biomarkers Congress which will be held on the 14th & 15th October 2013 at the Hilton Manchester Deansgate, UK. Our esteemed experts will explore the progression of oncology biomarker research from initial discovery through to the development of fully validated companion diagnostics.

Too often, the diagnosis of cancer happens in the late stages of the disease; molecular biomarkers provide a promising prospect for the detection of early stage cancer. On day one, our industry leaders will discuss the latest screening methods, the use of oncology imaging biomarkers and CTCs as PD markers in clinical trials. Our internationally renowned speakers will also assess the latest profiling technologies and their impact on biomarker development.

Following the success of many biomarkers in clinical trials, why are there still very few advances in the development of companion diagnostics? On day two, the discussions will focus on the role of tumour banks in personalised medicine, strategies for the co-development of drug and diagnostics and methods of assay development for the validation of companion diagnostics. Our experts will also discuss the importance of partnering relationships in enhancing the safety and efficacy of personalised medicine.

This two day congress, co-located with our 2nd Annual Oncology Clinical Development congress is a must for those looking to implement effective biomarker and companion diagnostic strategies.

2013 Oncology Biomarkers & Oncology Clinical Development Sponsors:

2012 Oncology Biomarkers & Oncology Clinical Development Sponsors:


Media Partners

top_logogenlogoabsavebanner_antibodies_180x75bioportfolio-logopharmavision_logoTechNet Communities(com)textbentham-logo100labsave-logogenomeweblogo-clearpharmcastpharmaphorum-logo-250ddw-logo200biosave-logomnt_logo_whiteclocate_logologo-300x97Espicom_BMI_Logo_COLiptechex200lab-bulletin-logonew200